Suchergebnisse - "Raetz E"

P360: EFFICACY AND SAFETY OF DARATUMUMAB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY T‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA: RESULTS FROM PHASE 2 DELPHINUS STUDY.

Autoren: Vora, A. Bhatla, T. Teachey, D. et al.

Quelle: HemaSphere; 2022 Supplement 3, Vol. 6, p260-261, 2p

Allelic expression imbalance of CDKN2A variants in childhood acute lymphoblastic leukemia.

Autoren: Tang, Zhexuan Pei, Kunlin Xu, Haoyu et al.

Quelle: Cellular Oncology (2211-3428); Jun2025, Vol. 48 Issue 3, p835-839, 5p

Schlagwörter: GENE expression, LYMPHOBLASTIC leukemia, GENETIC variation, CYCLIN-dependent kinase inhibitors, ACUTE leukemia

Hydration Meets Regulation: Insights into Bicarbonate Mineral Water and Acid–Base Balance.

Autoren: Mansouri, Katharina Hanh, Thierry Hahn, Andreas

Quelle: Nutrients. Jul2025, Vol. 18 Issue 14, p2291. 45p.

A single non-coding SNP in FPGS modulates folate drug efficacy in acute lymphoblastic leukemia: data-driven exploration and experimental validation.

Autoren: Yu, Wenliang Li, Chenyang Meng, Yuning et al.

Quelle: Molecular Biomedicine; 11/21/2025, Vol. 6 Issue 1, p1-18, 18p

Schlagwörter: METHOTREXATE, LYMPHOBLASTIC leukemia, CREB protein, INDIVIDUALIZED medicine, GENETIC markers, GENETIC variation, FOLIC acid metabolism, BIOMARKERS

Chemosensitizing effect of apigenin on T-ALL cell therapy.

Autoren: Huseynova, Nigar Baran, Züleyha Khalilov, Rovshan et al.

Quelle: Frontiers in Pharmacology; 2025, p1-10, 10p

Schlagwörter: APIGENIN, ASPARAGINASE, MITOCHONDRIAL pathology, CYTOTOXINS, T cells, CHEMOSENSITIZERS, APOPTOSIS, CELL cycle

Prognostic value of dynamic minimal residual disease monitoring for adolescent and adult T-lymphoblastic leukemia/lymphoma.

Autoren: Yang, Ying Zhang, Xin Jiang, Nenggang et al.

Quelle: Annals of Hematology; Nov2025, Vol. 104 Issue 11, p5935-5946, 12p

Data Sharing, Biopsies and Patient Confidentiality in a Precision Medicine Trial for Childhood Cancer: A Mixed Method Study of Parents, Oncologists, and Scientists' Perspectives.

Autoren: Lei, Yvanna Hetherington, Kate Daly, Rebecca et al.

Quelle: Journal of Personalized Medicine; Nov2025, Vol. 15 Issue 11, p531, 18p

Comprehensive Epigenome-Wide Profiling Reveals Distinctive DNA Methylation Signatures and Potential Prognostic Biomarkers in Mexican Pediatric B-ALL.

Autoren: Fong-López, Alan Alberto Núñez-Enríquez, Juan Carlos Bekker-Méndez, Vilma Carolina et al.

Quelle: International Journal of Molecular Sciences; Nov2025, Vol. 26 Issue 21, p10261, 25p

Schlagwörter: DNA methylation, BIOMARKERS, LYMPHOBLASTIC leukemia, EPIGENETICS, EPIGENOMICS, PROGNOSIS, CHILDHOOD cancer

Geografische Kategorien: MEXICO

Glycolysis Induces Abnormal Transcription Through Histone Lactylation in T-cell Acute Lymphoblastic Leukemia Open Access.

Autoren: Wu, Wenyan Zhang, Jingyi Sun, Huiying et al.

Quelle: Genomics, Proteomics & Bioinformatics; Apr2025, Vol. 23 Issue 2, p1-17, 17p

CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues.

Autoren: Alati, Caterina Pitea, Martina Molica, Matteo et al.

Quelle: Cancers; Sep2025, Vol. 17 Issue 18, p3027, 17p

Schlagwörter: GENE therapy, T cells, SURVIVAL rate, IMMUNOTHERAPY, GENOME editing, GENE expression profiling, LYMPHOBLASTIC leukemia, CANCER patient psychology, PROGRESSION-free survival, CELL receptors, B cells, B cell lymphoma

Key Common Genes with LTF and MMP9 Between Sepsis and Relapsed B-Cell Lineage Acute Lymphoblastic Leukemia in Children.

Autoren: Xiao, Ying-Ping Cheng, Yu-Cai Chen, Chun et al.

Quelle: Biomedicines; Sep2025, Vol. 13 Issue 9, p2307, 18p

Schlagwörter: SEPSIS, LACTOFERRIN, B cells, BIOMARKERS, GENE expression, LEUKEMIA, DRUG target, MATRIX metalloproteinases

Iron overload promotes myeloid differentiation of normal hematopoietic stem cells and educates macrophage mediated immunosuppression in acute myeloid leukemia.

Autoren: Yang, Feifei Luo, Shulin Yang, Dan et al.

Quelle: Frontiers in Immunology; 2025, p1-17, 17p

Schlagwörter: IRON overload, HEMATOPOIETIC stem cells, ACUTE myeloid leukemia, IMMUNE checkpoint proteins, MACROPHAGE activation, MYELOID leukemia, STEM cells, INTERLEUKIN-6

Multi‐omics integration analysis identifies INPP4B as a T‐cell‐specific activation suppressor.

Autoren: Peng, Ting Fang, Qing Zhao, Zihao et al.

Quelle: Clinical & Translational Medicine; Aug2025, Vol. 15 Issue 8, p1-17, 17p

Schlagwörter: T cells, T-cell exhaustion, IMMUNOSUPPRESSION, TUMOR microenvironment, PHOSPHATIDYLINOSITOL 3-kinases, MULTIOMICS, DORMANCY (Biology), IMMUNE response

Outcome of childhood ALK‐positive anaplastic large cell lymphoma relapses: Real‐life experience of the French Society of Pediatric Oncology (SFCE) cohort of 75 French children.

Autoren: Pereira, Victor Barthoulot, Maël Aladjidi, Nathalie et al.

Quelle: Pediatric Blood & Cancer; Jan2025, Vol. 72 Issue 1, p1-10, 10p

Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study.

Autoren: Leotta, Salvatore Markovic, Uros Duminuco, Andrea et al.

Quelle: Annals of Hematology; Sep2024, Vol. 103 Issue 9, p3701-3712, 12p

Schlagwörter: LYMPHOBLASTIC leukemia, ACUTE leukemia, OVERALL survival, UNIVARIATE analysis, MULTIVARIATE analysis

Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience.

Autoren: McCall, David Alqahtani, Shaikha Budak, Moriah et al.

Quelle: Cancers; Nov2024, Vol. 16 Issue 22, p3886, 11p

Schlagwörter: CANCER treatment, FEBRILE neutropenia, RESEARCH funding, ADENOSINES, SALVAGE therapy, TREATMENT effectiveness, RETROSPECTIVE studies, DESCRIPTIVE statistics, CANCER chemotherapy, MEDICAL records, ACQUISITION of data, SEPSIS, CONFIDENCE intervals, SPECIALTY hospitals, DRUG tolerance, OVERALL survival, DISEASE progression, DISEASE risk factors

Geografische Kategorien: TEXAS

Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children's Cancer Group.

Autoren: Goto, Hiroaki Kada, Akiko Ogawa, Chitose et al.

Quelle: International Journal of Hematology; Nov2024, Vol. 120 Issue 5, p631-638, 8p

Cell softness renders cytotoxic T lymphocytes and T leukemic cells resistant to perforin-mediated killing.

Autoren: Zhou, Yabo Wang, Dianheng Zhou, Li et al.

Quelle: Nature Communications; 2/19/2024, Vol. 15 Issue 1, p1-16, 16p

Schlagwörter: CYTOTOXIC T cells, T cells, CANCER cells, YAP signaling proteins, PERFORINS

Author Index to Volume 16.

Quelle: Leukemia (08876924); Dec2002, Vol. 16 Issue 12, p2465, 11p

Schlagwörter: LEUKEMIA, AUTHORS

Molecularly Targeted Small Molecule Inhibitor Therapy for Pediatric Acute Lymphoblastic Leukemia: A Comprehensive Review of Clinical Trials.

Autoren: Peccatori, Nicolò Brivio, Erica Lissat, Andrej et al.

Quelle: Cancers; Oct2025, Vol. 17 Issue 20, p3322, 41p

Schlagwörter: ANTINEOPLASTIC agents, THERAPEUTIC use of protease inhibitors, RISK assessment, DNA methyltransferases, MITOGEN-activated protein kinases, GENOMICS, CANCER relapse, IMMUNOTHERAPY, PROTEIN-tyrosine kinase inhibitors, AZACITIDINE, TREATMENT effectiveness, CANCER chemotherapy, PATIENT-centered care, PARADIGMS (Social sciences), JANUS kinases, DASATINIB, BORTEZOMIB, GENE expression profiling, MTOR inhibitors, DECITABINE, LYMPHOBLASTIC leukemia, INDIVIDUALIZED medicine, NEUROTRANSMITTER uptake inhibitors, IMATINIB, NILOTINIB, EVEROLIMUS, SEQUENCE analysis, CYCLIN-dependent kinases, RAPAMYCIN, HISTONE deacetylase, CHEMICAL inhibitors, CHILDREN